54 213 54 213 (Lithium 150 mg)

Pill imprint 54 213 54 213 has been identified as Lithium carbonate 150 mg.

Lithium is used in the treatment of bipolar disorder; borderline personality disorder; mania; depression; schizoaffective disorder (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for 54 213 54 213 (Lithium 150 mg)

Lithium carbonate 150 mg 54 213 54 213
Lithium carbonate 150 mg 54 213 54 213
Lithium carbonate 150 mg 54 213 54 213
Lithium carbonate
Imprint:
54 213
54 213
Strength:
150 mg
Color:
White
Size:
4.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Roxane Laboratories, Inc.
National Drug Code (NDC):
00054-8526
Inactive Ingredients:
FD&C Red No. 40
gelatin
sodium lauryl sulfate
magnesium silicate
titanium dioxide
ferrosoferric oxide
povidone k30
shellac
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00054-2526 Roxane Laboratories,Inc.

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web3)